Tilray Brands reported its Q1 2025 financial results, showing a net revenue increase of 13% to $200 million compared to $177 million in the prior year quarter. The company also reported a net loss improvement by 38% to $34.7 million from $55.9 million in the same period last year. Adjusted EPS was $(0.01), beating the $(0.04) estimate, although sales of $200.044 million missed the $219.295 million estimate. The positive outlook on cannabis legalization contributed to the stock gains. Tilray Brands' Q1 2025 results highlight significant progress and optimism in the cannabis sector.